Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Eczacibasi Capintec Divestment Talks Signal Pharma Refocus?

Executive Summary

Eczacibasi is in talks to sell its US-based nuclear medicine operation Capintec, in a move that appears to signal an intention by the Turkish healthcare group to focus again on the mainstream pharma sector.


Related Content

Indo-Turkish Biosimilar Connections Build


Related Companies